MySpace


Allele

Allele Biotechnology


Last Updated: 11/18/2009

Send Message
Instant Message
Email to a Friend
Subscribe

Gender: Male
Status: Single
Age: 19
Sign: Capricorn

City: San Diego
State: California
Country: US
Signup Date: 5/8/2009

Blog Archive
[Older      Newer]
 /  / 
December 2, 2009 - Wednesday 


http://allelebiotech.com/blogs/2009/12/constructio...

This week's Allele Blog is on building cell image libraries. The weekly promotion and new product of the week are announced in Wednesday blog as usual

November 19, 2009 - Thursday 


http://allelebiotech.com/blogs/2009/11/rnai-design...

Allele Biotech New Product/Service of the week Nov16-22, 2009

November 18, 2009 - Wednesday 


http://allelebiotech.com/blogs/2009/11/rnai-design...

RNAi screening has been conducted to identify correlations between gene functions and cellular phenotypes such as synthetic lethality among DNA damage signaling and repair pathway factors. Successfully performing high throughput screenings requires capabilities of efficient RNAi design, viral packaging, fluorescent proteins, and advanced

November 17, 2009 - Tuesday 
November 11, 2009 - Wednesday 
October 28, 2009 - Wednesday 

Packaging lentiviruses or retroviruses is not a routine procedure that every biology lab performs even if there is need to use it. A viral packaging protocol normally begins with preparation of purified transfer plasmid DNA, a miniprep should be enough for a few transfections. The virus backbone plasmid is either co-transfected into commonly used cells with helper plasmids that provide the essential proteins required for particle packaging, or transfected into established helper cell lines that express the required proteins from integrated transgenes. After incubation of packaging cells for a couple of days, viruses are collected and tittered. Titer determination is somewhat tricky for the inexperienced. Using a control virus expressing a fluorescent protein can make this step convenient.

Commonly known facts:

1) Lentiviruses are packaged at a titer of 10^6 IU/ml without concentrating steps.

This needs update since with more advanced technologies lentiviruses can be packaged routinely at 10^8 IU/ml. With further concentrating, the titer can be easily above 10^11 IU/ml. Retroviruses can be packaged to similar titers as well.

2) Using packaging cell lines gives the highest possible titer

While packaging cell lines (such as Allele’s popular Phoenix Eco and Ampho cells for retrovirus packaging) provides maybe the most convenient method for packaging, the yield will not reach the highest potential. Packaging cell lines may also lose their capability for packaging after continued culturing, requiring periodic selection with antibiotics and functional tests, as we do here at Allele.

3) Retroviruses are always collected in one shot after transfection into packaging cells

If the transfer vector has oriP/EBNA1 episomal maintenance system, such as some of the Phoenix vectors Allele offers, the plasmids may continue to express for up to 30 days. With puromycin selection, the titer of retrovirus produced from Eco or Ampho cells can reach 10^7 IU/ml.

This week’s promotion (102509-103109): 10% off across the board of Allele Biotech’s custom services, for an example, check out our world-leading baculovirus protein expression.

New Product/Service of the Week: Introduction of Custom Viral Packaging Service. Routine titer of 10^8 IU/ml, as high as 10^10 IU/ml, option to include cloning. Signature service ABP-CS-MERV002 provides more than 200 million particles at $7/million particles. These are game-changing prices for the viral packaging service market based on superior technologies!

October 19, 2009 - Monday 
US scientists have contributed so much to knowledge and logic, and translated many principles and theories to daily used products.  Yet, the US public don't quite see that.

http://www.allelebiotech.com/News//index.php?mod=article&cat=ScienceNews&article=150
October 16, 2009 - Friday 


http://allelebiotech.com/blogs/2009/10/competition...

n September, LifeTech brought suit against Illumina for patent infringement; in October Illumina countered with suits of its own. While the fight in court may be long and only sprinkled with occasional fireworks, the competition in the market could be fierce and should ultimately decide on whose technology is superior and offered at bette

September 18, 2009 - Friday 


http://allelebiotech.com/blogs/2009/09/hplc-purifi...

Learn about why you need to be careful with your siRNA concentrations, and promo for Allele's All-HPLC siRNA

September 10, 2009 - Thursday 

Category: Jobs, Work, Careers

................

Cancer stem cells (CSCs) have been a recent focus for cancer and stem cell researchers.  It is believed that cancerous tumors contain stem cells that can self renew and are often resistant to drug treatment.  Isolating and charactering CSCs have been the topic of several NIH grant solicitations this year, including the stimulus grant rounds.....

.. ..

Nature published an article on 090909 showing that a specific type of stem cells, CARNs, for castration-resistant Nkx3.1-expressing cells, may contribute to prostate cancer growth. The normal functions of these cells are to regenerate semen producing tissues that line the inside of the gland.  If their growth is unchecked by cancer suppressors, CARNs may become the source of cancer.  These cells are male sex hormone androgen-independent and maybe insensitive to androgen-based treatment.  This finding would also alter previous theory that prostate cancer originates from basal stem cells that later differentiate into luminal cells; "Instead, CARNs may represent a luminal origin for prostate cancer” said co-author Michael Shen of ....Columbia.. ..University.. ..Medical.. ..Center.... (quoted from Reuers news).....

.. ..

The method for identifying these cells used in the paper was genetic lineage-marking, which traced homeobox gene Nkx3-1 expression to rare luminal cells that express in the absence of testicular androgens. 


More to the point Biology News here http://www.allelebiotech.com/News//index.php?mod=article&cat=iPSStemCells&article=78
....

.. ..